Stockreport

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug [Yahoo! Finance]

Solid Biosciences Inc.  (SLDB) 
Last solid biosciences inc. earnings: 8/14 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investors.solidbio.com/investor-relations
PDF candidate, SGT-003, which is being developed as a gene therapy for Duchenne muscular dystrophy (DMD). The Rare Pediatric Disease designation is granted by the FDA to m [Read more]